448
H. Jin
the PRECISE study: A 180-Day, prospective, multicenter, pivotal trial. Diabet Care 40(1):63–
68. https://doi.org/10.2337/dc16-1525
12. Zhang J, Xiang Y, Wang M, Basu A, Lu Y (2016) Dose-dependent response of personal
glucose meters to nicotinamide coenzymes: applications to point-of-care diagnostics of many
non-glucose targets in a single step. Angew Chem Int Ed Engl 55(2):732–736. https://doi.org/
10.1002/anie.201507563
13. Modi A, Morou-Bermudez E, Vergara J, Patel RP, Nichols A, Joshipura K (2017) Validation
of two point-of-care tests against standard lab measures of NO in saliva and in serum. Nitric
Oxide 64:16–21. https://doi.org/10.1016/j.niox.2017.01.009
14. Wood CS, Thomas MR, Budd J, Mashamba-Thompson TP, Herbst K, Pillay D, Peeling RW,
Johnson AM, McKendry RA, Stevens MM (2019) Taking connected mobile-health diagnostics of infectious diseases to the field. Nature 566(7745):467–474. https://doi.org/10.1038/
s41586-019-0956-2
15. Karkouti K, Callum J, Wijeysundera DN, Rao V, Crowther M, Grocott HP, Pinto R, Scales
DC (2016) Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered
randomized controlled trial. Circulation 134(16):1152–1162. https://doi.org/10.1161/circul
ationaha.116.023956
16. Jain A, Graveline A, Waterhouse A, Vernet A, Flaumenhaft R, Ingber DE (2016) A shear
gradient-activated microfluidic device for automated monitoring of whole blood haemostasis
and platelet function. Nat Commun 7:10176. https://doi.org/10.1038/ncomms10176
17. Eichner SF, Timpe EM (2004) Urinary-based ovulation and pregnancy: point-of-care testing.
Ann Pharmacother 38(2):325–331. https://doi.org/10.1345/aph.1D210
18. Pastuszek E, Lukaszuk A, Kunicki M, Mockun J, Kloss G, Malinowska I, Czyzyk A,
Meczekalski B, Lukaszuk K (2017) New AMH assay allows rapid point of care measurements of ovarian reserve. Gynecol Endocrinol 33(8):638–643. https://doi.org/10.1080/095
13590.2017.1306735
19. Shochet T, Comstock IA, Ngoc NTN, Westphal LM, Sheldon WR, Loc LT, Blum J, Winikoff
B, Blumenthal PD (2017) Results of a pilot study in the U.S. and Vietnam to assess the utility
and acceptability of a multi-level pregnancy test (MLPT) for home monitoring of hCG trends
after assisted reproduction. BMC Womens Health 17(1):67. https://doi.org/10.1186/s12905017-0422-y
20. Grossman HB, Messing E, Soloway M, Tomera K, Katz G, Berger Y, Shen Y (2005) Detection
of bladder cancer using a point-of-care proteomic assay. JAMA 293(7):810–816. https://doi.
org/10.1001/jama.293.7.810
21. Davenport M, Mach KE, Shortliffe LMD, Banaei N, Wang TH, Liao JC (2017) New and
developing diagnostic technologies for urinary tract infections. Nat Rev Urol 14(5):296–310.
https://doi.org/10.1038/nrurol.2017.20
22. Lei R, Huo R, Mohan C (2020) Current and emerging trends in point-of-care urinalysis tests.
Expert Rev Mol Diagn 20(1):69–84. https://doi.org/10.1080/14737159.2020.1699063
23. Taylor JR, Lopez LM (2004) Cholesterol: point-of-care testing. Ann Pharmacother 38(7–
8):1252–1257. https://doi.org/10.1345/aph.1D269
24. Rapi S, Bazzini C, Tozzetti C, Sbolci V, Modesti PA (2009) Point-of-care testing of cholesterol
and triglycerides for epidemiologic studies: evaluation of the multicare-in system. Transl Res
153(2):71–76. https://doi.org/10.1016/j.trsl.2008.11.010
25. Mallett SV, Armstrong M (2015) Point-of-care monitoring of haemostasis. Anaesthesia 70
Suppl 1:73–77, e25-76. https://doi.org/10.1111/anae.12909
26. Levi M (2017) Point-of-care testing in acute hemorrhagic and thrombotic states. Semin
Thromb Hemost 43(4):364–366. https://doi.org/10.1055/s-0037-1599152
27. Harpaz D, Eltzov E, Seet RCS, Marks RS, Tok AIY (2017) Point-of-care-testing in acute stroke
management: an unmet need ripe for technological harvest. Biosens (Basel) 7(3). https://doi.
org/10.3390/bios7030030
28. Vashist SK, Luong JH (2016) Trends in in vitro diagnostics and mobile healthcare. Biotechnol
Adv 34(3):137–138. https://doi.org/10.1016/j.biotechadv.2016.03.007
H. Jin
the PRECISE study: A 180-Day, prospective, multicenter, pivotal trial. Diabet Care 40(1):63–
68. https://doi.org/10.2337/dc16-1525
12. Zhang J, Xiang Y, Wang M, Basu A, Lu Y (2016) Dose-dependent response of personal
glucose meters to nicotinamide coenzymes: applications to point-of-care diagnostics of many
non-glucose targets in a single step. Angew Chem Int Ed Engl 55(2):732–736. https://doi.org/
10.1002/anie.201507563
13. Modi A, Morou-Bermudez E, Vergara J, Patel RP, Nichols A, Joshipura K (2017) Validation
of two point-of-care tests against standard lab measures of NO in saliva and in serum. Nitric
Oxide 64:16–21. https://doi.org/10.1016/j.niox.2017.01.009
14. Wood CS, Thomas MR, Budd J, Mashamba-Thompson TP, Herbst K, Pillay D, Peeling RW,
Johnson AM, McKendry RA, Stevens MM (2019) Taking connected mobile-health diagnostics of infectious diseases to the field. Nature 566(7745):467–474. https://doi.org/10.1038/
s41586-019-0956-2
15. Karkouti K, Callum J, Wijeysundera DN, Rao V, Crowther M, Grocott HP, Pinto R, Scales
DC (2016) Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered
randomized controlled trial. Circulation 134(16):1152–1162. https://doi.org/10.1161/circul
ationaha.116.023956
16. Jain A, Graveline A, Waterhouse A, Vernet A, Flaumenhaft R, Ingber DE (2016) A shear
gradient-activated microfluidic device for automated monitoring of whole blood haemostasis
and platelet function. Nat Commun 7:10176. https://doi.org/10.1038/ncomms10176
17. Eichner SF, Timpe EM (2004) Urinary-based ovulation and pregnancy: point-of-care testing.
Ann Pharmacother 38(2):325–331. https://doi.org/10.1345/aph.1D210
18. Pastuszek E, Lukaszuk A, Kunicki M, Mockun J, Kloss G, Malinowska I, Czyzyk A,
Meczekalski B, Lukaszuk K (2017) New AMH assay allows rapid point of care measurements of ovarian reserve. Gynecol Endocrinol 33(8):638–643. https://doi.org/10.1080/095
13590.2017.1306735
19. Shochet T, Comstock IA, Ngoc NTN, Westphal LM, Sheldon WR, Loc LT, Blum J, Winikoff
B, Blumenthal PD (2017) Results of a pilot study in the U.S. and Vietnam to assess the utility
and acceptability of a multi-level pregnancy test (MLPT) for home monitoring of hCG trends
after assisted reproduction. BMC Womens Health 17(1):67. https://doi.org/10.1186/s12905017-0422-y
20. Grossman HB, Messing E, Soloway M, Tomera K, Katz G, Berger Y, Shen Y (2005) Detection
of bladder cancer using a point-of-care proteomic assay. JAMA 293(7):810–816. https://doi.
org/10.1001/jama.293.7.810
21. Davenport M, Mach KE, Shortliffe LMD, Banaei N, Wang TH, Liao JC (2017) New and
developing diagnostic technologies for urinary tract infections. Nat Rev Urol 14(5):296–310.
https://doi.org/10.1038/nrurol.2017.20
22. Lei R, Huo R, Mohan C (2020) Current and emerging trends in point-of-care urinalysis tests.
Expert Rev Mol Diagn 20(1):69–84. https://doi.org/10.1080/14737159.2020.1699063
23. Taylor JR, Lopez LM (2004) Cholesterol: point-of-care testing. Ann Pharmacother 38(7–
8):1252–1257. https://doi.org/10.1345/aph.1D269
24. Rapi S, Bazzini C, Tozzetti C, Sbolci V, Modesti PA (2009) Point-of-care testing of cholesterol
and triglycerides for epidemiologic studies: evaluation of the multicare-in system. Transl Res
153(2):71–76. https://doi.org/10.1016/j.trsl.2008.11.010
25. Mallett SV, Armstrong M (2015) Point-of-care monitoring of haemostasis. Anaesthesia 70
Suppl 1:73–77, e25-76. https://doi.org/10.1111/anae.12909
26. Levi M (2017) Point-of-care testing in acute hemorrhagic and thrombotic states. Semin
Thromb Hemost 43(4):364–366. https://doi.org/10.1055/s-0037-1599152
27. Harpaz D, Eltzov E, Seet RCS, Marks RS, Tok AIY (2017) Point-of-care-testing in acute stroke
management: an unmet need ripe for technological harvest. Biosens (Basel) 7(3). https://doi.
org/10.3390/bios7030030
28. Vashist SK, Luong JH (2016) Trends in in vitro diagnostics and mobile healthcare. Biotechnol
Adv 34(3):137–138. https://doi.org/10.1016/j.biotechadv.2016.03.007